1. Yan, K., et al., Transcriptomic heterogeneity of cultured ADSCs corresponds to embolic risk in the host. iScience, 2022. 25(8): p. 104822.2. Ma, F., et al., Protocol to assess fatal embolism risks from human stem cells. STAR Protocols, 2023. 4(2): p. 102268.
评论
加载更多